Supported Research

Fanconi Anemia Type C Gene Therapy:  Use of a HSV1/EBV Vector in Vitro and in Vivo Studies

2000 | UNC School of Medicine | Research Grant

Amount Funded: $62,042

Researchers: Jean-Michel Vos